Celldex Therapeutics
CLDX
CLDX
134 hedge funds and large institutions have $295M invested in Celldex Therapeutics in 2017 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 42 increasing their positions, 44 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
0.19% less ownership
Funds ownership: 4.56% → 4.37% (-0.19%)
5% less repeat investments, than reductions
Existing positions increased: 42 | Existing positions reduced: 44
4% less funds holding
Funds holding: 140 → 134 (-6)
Holders
134
Holding in Top 10
2
Calls
$1.4M
Puts
$1.27M
Top Buyers
| 1 | +$29.2M | |
| 2 | +$15M | |
| 3 | +$4.61M | |
| 4 |
Renaissance Technologies
New York
|
+$1.83M |
| 5 |
State of Wisconsin Investment Board
Madison,
Wisconsin
|
+$1.82M |
Top Sellers
| 1 | -$18.9M | |
| 2 | -$3.48M | |
| 3 | -$3.32M | |
| 4 |
TCMG
TSP Capital Management Group
Summit,
New Jersey
|
-$3.14M |
| 5 |
DM
Deerfield Management
New York
|
-$2.24M |